Welcome to FeNO by NIOX®, the only podcast that will tell you what you need to know about FeNO testing.
FeNO stands for fractional exhaled nitric oxide (NO). Testing FeNO can help with more accurate asthma diagnosis and better management, leading to improved patient outcomes right at the point-of-care.
Our FeNO by NIOX® podcast covers loads of different FeNO related topics. Listen today to learn more about FeNO testing.
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.
NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, with a simple touch screen interface and intuitive design, and can be used in a variety of settings, including clinics, hospitals, and primary care settings.
The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals.
Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive1 tool to help them better diagnose and manage asthma.
Get started with NIOX VERO®
Join the thousands of healthcare professionals who have already performed over 40 million FeNO tests with NIOX®, and improve patient outcomes.